KLK3 and metastatic prostate carcinoma: Sharma et al27 investigated the association between PSA screening and the incidence of metastatic prostate cancer using state-level data from the North American Association of Central Cancer Registries from 1999 to 2017 and the Behavioral Risk Factor Surveillance System from 2001 to 2018.